María
Díez Campelo
Profesora Asociada CC. Salud
University of North Carolina at Chapel Hill
Chapel Hill, Estados Unidos
Publications in collaboration with researchers from University of North Carolina at Chapel Hill (2)
2021
-
Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML (Leukemia, (2021), 35, 7, (2119-2124), 10.1038/s41375-021-01125-4)
Leukemia
-
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
Leukemia